Effect of RU486 on hepatic and adipocyte gene expression improves diabetes control in obesity-type 2 diabetes

Hormone and Metabolic Research

Volumn 41, Issue 12, 2009, Pages 899-904

  Taylor, A I ^a   Frizzell, N ^a   McKillop, A M ^a   Flatt, P R ^a   Gault, V A ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Diabetes; Glucocorticoid receptor; Glucose tolerance; Insulin sensitivity; Ob ob mice; RU486

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; GLUCOCORTICOID RECEPTOR; GLUCOSE; GLUCOSE 6 PHOSPHATASE; INSULIN; MESSENGER RNA; MIFEPRISTONE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PHOSPHOENOLPYRUVATE CARBOXYKINASE C; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES CONTROL; DISEASE MODEL; DRUG EFFECT; EPIDIDYMIS FAT; EVOKED RESPONSE; FOOD INTAKE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; INSULIN SENSITIVITY; LIVER; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROVOCATION TEST; RECEPTOR BLOCKING; TREATMENT DURATION; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ADIPOSE TISSUE, WHITE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; EPIDIDYMIS; FASTING; FEEDING BEHAVIOR; GENE EXPRESSION REGULATION; GLUCOSE TOLERANCE TEST; INSULIN; LIVER; MALE; MICE; MICE, OBESE; MIFEPRISTONE; OBESITY; PANCREAS; RNA, MESSENGER; TRIGLYCERIDES;

MUS;

EID: 71849115565     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0029-1234071     Document Type: Article

References (38)

1. Schoneveld OJ, Gaemers IC, Lamers WH. Mechanisms of glucocorticoid signalling. Biochem Biophys Acta 2004 1680 114-128
2. Kassel O, Herrlich P. Crosstalk between the glucocorticoid receptor and other transcription factors: Molecular aspects. Mol Cell Endocrinol 2007 275 13-29
3. Kino T. Tissue Glucocorticoid sensitivity: Beyond stochastic regulation on the diverse actions of glucocorticoids. Horm Metab Res 2007 39 420-424
4. Friedman JE, Yun JS, Patel YM, McGrane MM, Hanson RW. Glucocortocoids regulate the induction of phosphoenolpyruvate carboxykinase (GTP) gene transcription during diabetes. J Biol Chem 1993 268 12952-12957
5. Pilkis SJ, Granner DK. Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Physiol 1992 54 885-909
6. McKay LI, Cidlowski JA. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signalling pathways. Endocrinol Rev 1999 20 435-459
7. Herbert J, Goodyer IM, Grossman AB, Hastings MH, de Kloet ER, Lightman SL, Lupien SJ, Roozendaal B, Seckl JR. Do corticosteroids damage the brain? J Neuroendocrinol 2006 18 393-411
8. Sivagurunathan S, Muir MM, Brennan TC, Seale JP, Mason RS. Influence of glucocorticoids on human osteoclast generation and activity. J Bone Miner Res 2005 20 390-398
9. Matero F, Boscaro M. Glucocorticoid-dependent hypertension. J Steroid Biochem Mol Biol 1992 43 409-413
10. Pasquali R, Vicennati V. The abdominal obesity phenotype and insulin resistance are associated with abnormalities of the hypothalamic-pituitary adrenal axis in humans. Horm Metab Res 2000 32 521-525
11. Mahajan DK, London SN. Mifepristone (RU486): A review. Fertil Steril 1997 68 967-976
12. Johanssen S, Allolio B. Mifepristone (RU486) in Cushing's Syndrome. Eur J Endocrinol 2007 157 561-569
13. Cadepond F, Ulmann A, Baulieu EE. RU486 (Mifepristone): Mechanism of action and clinical uses. Annu Rev Med 1997 48 129-156
14. Jay MA, Ren J. Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus. Curr Diabetes Rev 2007 3 33-39
15. Livingstone DE, Walker BR. Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats. J Pharmacol Exp Therap 2003 305 167-172
16. Kim W, Egan JM. The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol Rev 2008 60 470-512
17. Bailey CJ, Flatt PR. Animal syndromes resembling type 2 diabetes. In: Pickup JC, Williams G (eds) Textbook of Diabetes (3rd ed) Oxford: Blackwell Science Ltd. 2003 25.1-25.30
18. Bailey CJ, Flatt PR, Atkins TW. Influence of genetic background and age on the expression of the obese hyperglycaemic syndrome in Aston ob/ob mice. Int J Obesity 1982 6 11-21
19. Gettys TW, Watson PM, Taylor IL, Collins S. RU-486 (Mifepristone) ameliorates diabetes but does not correct deficient -adrenergic signalling in adipocytes from mature C57BL/J6-ob/ob mice. Int J Obesity 1997 21 865-873
20. Flatt PR, Bailey CJ. Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice. Diabetologia 1981 20 573-577
21. McClean PL, Irwin N, Cassidy RS, Holst JJ, Gault VA, Flatt PR. GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet. Am J Physiol Endocrinol Metab 2007 293 1746-1755
22. Saltiel AR, Kahn R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001 414 799-806
23. Dirlewanger M, Schneiter PH, Paquot N, Jequier E, Rey V, Tappy L. Effects of glucocorticoids on hepatic sensitivity to insulin and glucagon in man. Clin Nutr 2000 19 29-34
24. Rognstad R. Rate-limiting steps in metabolic pathways. J Biol Chem 1979 254 1875-1878
25. Imai E, Stromstedt PE, Quinn PG, Carlstedt-Duke J, Gustafsson JA, Granner DK. Characterization of a complex glucocorticoid response unit in the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol 1990 10 4172-4179
26. Vander Kooi BT, Onuma H, Oeser JK, Svitek CA, Allen SR, Vander Kooi CW, Chazin WJ, OBrien RM. The Glucose-6-Phosphatase catalytic subunit gene promoter contains both positive and negative glucocorticoid response elements. Mol Endocrinol 2005 19 3001-3022
27. Liu Y, Nakagawa Y, Wang Y, Sakurai R, Tripathi PV, Lufty K, Friedman TC. Increased glucocorticoid receptor and 11{beta}-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice. Diabetes 2005 54 32-40
28. Friedman JE, Sun Y, Ishizuka T, Farrell CJ, McCormack SE, Herron LM, Hakimi P, Lechner P, Yun JS. Phosphoenolpyruvate carboxykinase (GTP) gene transcription and hyperglycemia are regulated by glucocorticoids in genetically obese db/db transgenic mice. J Biol Chem 1997 272 31475-31481
29. Gómez-Valadés AG, Méndez-Lucas A, Vidal-Alabró A, Blasco FX, Chillon M, Bartrons R, Bermúdez J, Perales JC. Pck1 gene silencing in the liver improves glycemia control, insulin sensitivity, and dyslipidemia in db/db mice. Diabetes 2008 57 2199-2210
30. Liu Y, Nakagawa Y, Wang Y, Liu L, Du H, Wang W, Ren X, Lufty K, Friedman TC. Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice. J Mol Endocrinol 2008 41 53-64
31. Jiang W, Fiordeliso JJ, Allan G, Linton O, Tannenbaum P, Xu J, Zhu P, Gunnet J, Demarest K, Lundeen S, Sui Z. Discovery of novel phosphorus-containing steroids as selective glucocorticoid receptor antagonist. Bioorg Med Chem Lett 2007 17 1471-1474 (Pubitemid 46251480)
32. Alberts P, Nilsson C, Selen G, Engblom LO, Edling NH, Norling S, Klingström G, Larsson C, Forsgren M, Ashkzari M, Nilsson CE, Fiedler M, Bergqvist E, Ohmen B, Bjorkstrand E, Abrahmsen LB. Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology 2003 144 4755-4762
33. Picard F, Wanatabe M, Schoonjans K, Lydon J, OMalley BW, Auwerx J. Progesterone receptor knockout mice have an improved glucose homeostasis secondary to -cell proliferation. Proc Natl Acad Sci USA 2002 99 15644-15648
34. Langley SC, York, DA. Effects of antiglucocorticoid RU 486 on development of obesity in obese fa/fa Zucker rats. Am J Physiol 1990 259 539-544
35. Fried SK, Russell CD, Grauso NL, Brolin RE. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J Clin Invest 1993 92 2191-2198
36. Ong JM, Simsolo RB, Saffari B, Kern PA. The regulation of lipoprotein lipase gene expression by dexamethasone in isolated rat adipocytes. Endocrinology 1992 130 2310-2316
37. Ottosson M, Mårin P, Karason K, Elander A, Björntorp P. Blockade of the glucocorticoid receptor with RU 486: effects in vitro and in vivo on human adipose tissue lipoprotein lipase activity. J Clin Endocrinol Metab 1995 78 375-380
38. Bailey CJ, Day C, Bray GA, Lipson LG, Flatt PR. Role of adrenal glands in the development of abnormal glucose and insulin homeostasis in genetically obese (ob/ob) mice. Horm Metab Res 1986 18 357-360